AI-Enabled Biopharma in 2026: Sponsor & CRO Playbook for Discovery, Evidence Generation, and Responsible AI
Abstract AI adoption in biopharma has moved from pilot projects to measurable operational impact. In 2026, the competitive difference is less about who has the largest model and more about who can demonstrate model credibility for a defined context of…